New York Medical College is chartered by the Regents of the State of New York, and all of its degree programs are authorized by the New York State Department of Education. The College is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Secondary Schools. All programs leading to professional licensure have special accreditation. The School of Medicine is accredited by the Liaison Committee on Medical Education (LCME). The Physical Therapy Program in the School of Public Health is accredited by the Commission on Accreditation in Physical Therapy Education (CAPTE). The Speech-Language Pathology Program in the School of Public Health is a candidate for accreditation by the Council on Academic Accreditation of the American Speech-Language-Hearing Association (ASHA).
New York Medical College is located in Valhalla, N.Y., in suburban Westchester County, within the nation's largest metropolitan region. The College, with an enrollment of 1,500 students, is committed to educating individuals for careers in the medical, science and health professions.
The College comprises three schools - a School of Medicine, conferring the M.D. degree, and two graduate schools, the Graduate School of Basic Medical Sciences and the School of Health Sciences and Practice, which offer M.S., M.P.H. and Ph.D. degrees in a wide range of program areas. The faculty is made up of more than 2,800 members including approximately 1,200 full time. In addition to their teaching responsibilities, many of the faculty enjoy international reputations for their clinical and scientific accomplishments. The university's 10,000 alumni are actively engaged in the practice of medicine, healthcare administration, public health, teaching and research throughout the nation and abroad.
The School of Medicine, founded in 1860, has a longstanding reputation for producing superior clinicians, both generalists and specialists. The university's wide range of affiliated hospitals, which include large urban medical centers, small suburban hospitals and technologically advanced regional tertiary care facilities, provide extensive resources and educational opportunities. The department of Continuing Medical Education offers a wide array of programs for physicians.
The Graduate School of Basic Medical Sciences educates future researchers and teachers, and prepares senior-level scientists and technicians to work in academia and industry. Of the approximately 200 students enrolled, half pursue their studies full time. Some 16 percent are international students. There are strong doctoral programs in cell biology and anatomy, biochemistry and molecular biology, pharmacology, experimental pathology, physiology, and microbiology and immunology. In addition, an M.D./Ph.D. degree program is available for those students capable of completing the rigorous program requirements.
The School of Health Sciences and Practice, which started in 1981 as the Graduate School of Health Sciences, offers graduate programs in public health and health science disciplines. Nearly 600 students from the tri-state area are enrolled. The majority are part-time students employed in the health professions in government agencies, private and public health agencies, private practices, hospitals, corporations, environmental and pharmaceutical laboratories, and community service organizations. Pursuing M.S., M.P.H. and doctoral degrees, the students are enrolled in programs such as physical therapy, international health, speech-language pathology, health services management and policy, health promotion and health quantitative sciences.
New York Medical College is the only academic biomedical research institution between New York City and Albany with some $47 million in sponsored programs of research, training, and service. Some of the most prestigious and respected biotechnology firms in the region call on the university to supplement their existing resources, develop new platform technologies, and explore new product ideas. Through the Division of Technology Development and Industry Sponsored Research, programs are being developed to ensure that scientific progress is released quickly to industry, thereby enabling new vaccines, diagnostic tests, and therapeutic drugs and devices to reach the marketplace, resulting in improved patient care.